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Abstract
Background: To culturally adapt and validate the Integrated Palliative care Outcome Scale to European Portuguese.
Methods: Multi-centred observational study with 2 assessment points. Data were collected in nine centres using
consecutive sampling. All patients were screened for eligibility. Inclusion criteria: ≥18 years, mentally fit to give
consent, diagnosed with an incurable, potentially life-threatening illness, read, write and understand Portuguese.
Translation and back translation with independent native speakers blind to the original measure created a
Portuguese version, which was culturally adapted using cognitive interviews. For psychometric testing, the COSMIN
checklist was followed. Reliability and content validity were assessed for patient and staff versions. Construct and
criterion validity were tested for patient version.
Results: 1703 individuals were screened between July 1st 2015 and February 2016, 135 (7.9%) were included. Mean
age was 66.8 years (SD 12.7), 58 (43%) were female. Most patients (109; 80.7%) had a cancer diagnosis. Cronbach’s
alpha showed good internal consistency, 0.657 for patient, 0.705 for staff versions. Intraclass correlation coefficient
testing reproducibility revealed very good reliability, 0.794–0.950 for patient and 0.456–0.925 for staff versions. There
was good content validity and significant results for construct validity. Physical symptoms were better detected by
females. IPOS could discriminate: practical issues in different places of care, based on cancer diagnosis, physical and
emotional symptoms based on life expectancy both for patient and professional dimensions, physical and
emotional symptoms based on phase of illness, for professional dimensions, and physical symptoms from the
patients’ viewpoint.
Conclusions: The Portuguese IPOS is a reliable and valid measure.
Keywords: Patient-centred outcome measures, Palliative care, Outcome measurement, Palliative care outcome
scale, Validation
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Background
The Integrated Palliative care Outcome Scale (IPOS) [1]
is a patient-centred outcome measure resulting from the
merge of two previously existing measures: the Palliative
care Outcome Scale and the Palliative care Outcome
Scale-Symptoms [2]. IPOS was developed at the request
of several clinicians wanting a more user-friendly measure
for clinical practice. Two versions were developed, one to
be self-reported by patients, and a staff-proxy-reported to
be filled by healthcare professionals, considering the
perceptions and holistic assessment of the symptoms and
other concerns the patient might have.
The aim of this study was twofold: (i) to translate,
culturally adapt and validate the original English IPOS
into Portuguese, and (ii) to compare the results obtained
by the two versions of IPOS.
Methods
Linguistic and cultural adaptation
We followed the internationally defined methodology for
the linguistic and cultural adaptation for the validation
of outcome measures proposed by the COnsensus-based
Standards for the selection of health Measurement IN-
struments (COSMIN) checklist [3] and the sequential
approach for the translation [4].
After seeking and getting consent from the authors of
the original IPOS measure, two independent bilingual
native Portuguese speaking translators, one clinical and
one non-clinical, both blind to the original English IPOS
for patients, created two Portuguese versions. Next, two
other native Portuguese speaking independent reviewers
not blind to the original IPOS developed a consensus
Portuguese version. This was then sent to two other in-
dependent native English-speaking translators, also blind
to the original English IPOS, who back translated it into
English. Comparing this back translated version with the
original one, the same reviewers developed a second
Portuguese consensus version.
Then, three clinical revisions were performed by one
specialist palliative care doctor, one specialist palliative
care nurse and one non-clinical researcher in palliative
care – all native Portuguese. These experts were asked
to look at both versions and comment for each question.
Three possible outcomes might arise: (1) question was
correctly written and no change was proposed, (2) ques-
tion was incorrectly phrased and an alternative question
was proposed; or (3) question was correctly written but
an alternative would better. Based on the patient version,
a final clinical review of the staff version of IPOS was
also performed by the same experts.
Next, cognitive interviews were performed with 12 pal-
liative care patients and nine healthcare professionals.
Each patient had an individual interview and professionals
were interviewed in two groups. The purpose of these
interviews was to check acceptability by patients and staff,
without ambiguity and redundancy and lack of important
items. A final Portuguese version was obtained [5].
Study design
This was a multi-centred observational study with two
assessment points. Data were collected in nine centres
using consecutive sampling. All patients attending the
participant services were screened for eligibility. Inclu-
sion criteria were to be 18 years or older, mentally fit to
give consent, diagnosed with an incurable, potentially
life-threatening illness, read, write and understand
Portuguese. Exclusion criteria included patients in
distress or cognitively impaired. All professionals who
provided care for participant patients were eligible for
this study. They filled the staff proxy IPOS independ-
ently from the corresponding patients.
A standard operating procedures manual was previ-
ously developed and distributed to all centres in the per-
son of the facilitator/champion leading the study locally.
After checking data quality, Little’s MCAR test was
implemented to verify if data were missing at random.
We adopted the following criteria: rates < 1% are trivial,
1–5% are manageable, 5–15% require sophisticated
statistical methods to handle, and > 15% may severely
impact any form of interpretation [6].
Ethical approvals were granted in accordance with the
1964 Helsinki declaration and its later amendments or
comparable ethical Standard be the following Ethics
Committees: S. João Hospital (no reference number),
Regional Health Authorities of Centro (reference 77/
2015) and of Lisbon and Tagus Valley (reference 6801/
CES/2015), Vila Nova de Gaia/Espinho Hospital Centre
(reference 275/2015), Lisbon Cancer Institute (reference
UIC/967 n° 89/2015), S. João de Deus Institute (refer-
ence CEISJD03_15); Lisbon Medicine Academic Centre
(reference 51/15), and Nordeste Health Local Unit (no
reference number). Informed written (signed) consent
was obtained from all participants (patients and health-
care professionals). SPSSv22 software was used.
Measures used
IPOS [1], the measure under study, is a brief, 19-item,
multidimensional scale designed to capture core con-
cerns in palliative care. Item 1 is an open question re-
garding the three main problems or worries the patient/
professional had in the past week; items 2 to 9 are set on
5-point Likert scales based on descriptors, item 2 lists
ten of the most common physical symptoms in a pallia-
tive population, with the possibility of an additional
three symptoms (not present in the list); item 3 is about
anxiety, item 4 pertains to family/friends worries, item 5
asks about depression; item 6 is feeling at peace; item 7
addresses sharing feelings with significant people; item 8
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is about information needs and item 9 concerns practical
problems related to their illness. In the patient version,
there is an extra item asking if they had filled the ques-
tionnaire alone or with help. At the very end, there is a
trigger in the form of a footnote noting that if the
patient became worried about any of the issues raised by
the questionnaire, they should/are advised to talk to
their healthcare professional about those worries.
Each of the ten physical symptoms and all the follow-
ing four emotional symptoms were linearly converted
into a 0–100 scale, in which higher scores corresponded
to higher severity symptoms. Additionally, items 7 to 9
were converted to a 0–100 scale representing the func-
tionality associated to each question. An average for
each symptom and functionality item was accordingly
computed.
The Portuguese EuroQol questionnaire (EQ-5D-3L)
[7] allows quantifying two main components of health
related quality of life: a first description of health status
in the form of five dimensions or domains and a nu-
meric value associated with the perceived global health
status by the individual. These components are used in
cost-utility economic evaluations, after transforming the
descriptive system into a unique utility score. There are
five items set in a 3-point Likert scale with descriptors.
The items pertain to mobility, self-care, usual activities,
pain/discomfort and anxiety/depression. It also has a nu-
meric analogue visual scale (EQ-VAS) from 0 (the worst
possible health state) to 100 (the best possible health
state) so that the respondent can quantify their health
state in the moment when filling the questionnaire. The
authors of the Portuguese version state that this measure
has good accessibility, reliability and validity in measur-
ing health [7, 8]. The obtained utility score ranges from
0 (death) to 1 (perfect health), allowing for negative
values corresponding to health state perceived as worse
than death.
The Portuguese translation of the European Organization
for Research and Treatment of Cancer Quality of Life
Questionnaire Core (EORTC QLQ-C30) [9, 10] is a 30-
item questionnaire, 24 items compose nine multi-item
scales, namely, five functional subscales (physical, role, cog-
nitive, emotional, and social); a global health/QoL subscale
and three symptom subscales (fatigue, pain, and nausea/
vomiting). The remaining six items are single-item asses-
sing symptoms commonly reported by cancer patients (dys-
pnoea, appetite loss, sleep disturbance, constipation, and
diarrhoea) and one remaining item related to the perceived
financial impact of cancer. All items are scored on 4-point
Likert scale ranging from 1 (not at all) to 4 (very much),
apart from two items of the global health/QoL subscale,
which use a modified 7-anchor linear analogue scale. All
scales range from 0 to 100. A high score for functional
scales and global health status/QoL represents a healthy
level of functioning and QoL. For each subscale, a score be-
tween 0 and 7 is considered normal, between 8 and 10
mild, between 11 and 14 moderate and between 15 and 21
severe. The authors conclude that the Portuguese EORTC
QLQ C-30 has good metric properties.
The Portuguese Hospital Anxiety and Depression
Scale (HADS) [11] screens for anxiety and depression
states and has 14 items divided into two subscales.
These are based on a 4-point Likert scale, with descrip-
tive answers, comprised of seven items each, scored
separately. The authors propose a clinical cut-off of 11
for depression and anxiety. The authors conclude that
the Portuguese HADS is reliable and valid to assess
depression and anxiety in different medical settings and
disease populations.
‘Phase of illness’ is a conceptualization of a patient’s
illness in five distinct, clinically meaningful phases—
stable, unstable, deteriorating, terminal, bereavement
(this last omitted in the present study) - developed in
context of the Australian Case Mix Classification. It can
be used as an indicator of acuity and reflects complexity
within the disease trajectory [12, 13].
Demographic and clinical variables were also collected.
The content in the open questions 1a, 1b and 1c was ag-
gregated to define the most prevalent worries occurring
in the previous week of completion.
Reliability
Reliability was addressed by the intertemporal stability
and the internal consistency. The intertemporal stability
was tested in inpatients and outpatients with a guarantee
of no clinical change, by intraclass correlation coefficient
(ICC), on average, in a 1-week test-retest design. A score
smaller that 0.5 is considered weak, between 0.5 and
0.75 moderate, between 0.75 and 0.9 good, and larger
than 0.9 excellent [14]. The inter-rater reliability be-
tween staff members was also assessed.
Internal consistency was tested by the Cronbach’s
alpha coefficient, which should have scores between 0.7
and 0.9 [15]. However, following author’s advice [1], we
also lowered the lower limit 0.6 due to the multi-
dimensionality and non-redundancy of IPOS [16].
The following two hypotheses were formulated:
H1: The Portuguese version of the IPOS shows good
intertemporal stability.
H2: The Portuguese version of the IPOS shows good
internal consistency.
Validity
Validity was addressed by the content, construct, and criter-
ion validity [15, 16]. The former has been tested through
the clinical reviews and the cognitive debriefing interviews.
Construct validity was tested by hypotheses with
known groups stratified by sociodemographic variables
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(age, gender, and education level) and some clinical vari-
ables (place of care, type of disease, life expectancy and
phase of illness).
The following hypotheses were raised:
H3: IPOS can discriminate based on the
sociodemographic variable age.
H4: IPOS can discriminate based on the
sociodemographic variable gender.
H5: IPOS can discriminate based on the
sociodemographic variable education level.
H6: IPOS can discriminate based on the
clinical variable place of care.
H7: IPOS can discriminate based on the clinical
variable type of disease.
H8: IPOS can discriminate based on the clinical
variable life expectancy.
H9: IPOS can discriminate based on the clinical
variable phase of illness.
Age and gender were not expected to influence IPOS
scores. Less educated patients might have more symp-
toms with greater impact on quality of life. Same
phenomenon was expected for unstable patients.
Normality tests were first performed. Two-sample inde-
pendent t-tests were applied when normality assumed; if
not, chi-squared and Mann-Whitney U tests were used.
P values below 0.05 are considered statistically significant.
To test the criterion validity, we used bivariate statis-
tical analyses (Pearson’s r correlation coefficients) be-
tween the dimensions of the Portuguese version of the
IPOS and other measuring instruments, namely EQ-5D-
3L (index and VAS), EORTC QLQ-C30 (functional index,
symptom scale, and quality of life) and HADS (anxiety
and depression) items. We hypothesised that items meas-
uring similar constructs would have higher correlations
and items measuring different constructs would have a
lower correlation. Correlations less than 0.3, between 0.3
and 0.5, and higher than 0.5 were defined as weak, moder-
ate and strong, respectively [17].
The following three hypotheses were formulated:
H10: IPOS dimensions are correlated with similar
EQ-5D-3L dimensions.
H11: IPOS dimensions are correlated with similar
EORTC QLQ-C30 dimensions.
H12: IPOS dimensions are correlated with similar
HADS dimensions.
We expect convergence between similar dimensions
and divergence for distinct dimensions’ scores.
Results
Linguistic and cultural adaptation
There were grammatical and content differences in the
first translation stage, regarding items/questions phras-
ing as well as the response categories. There were differ-
ences in the backward translation, namely verb tenses
and the use of synonyms, rather than the direct transla-
tion of words. Both issues were resolved by discussion
with both reviewers.
The clinical revisions flagged differences in verb tenses
in three items which were discussed, and changes were
made to create the final version. In relation to the cogni-
tive interviews to determine content (face) validity, these
were conducted in two palliative care services in two
major hospitals in the North of Portugal. Twelve patients
were individually interviewed, and nine healthcare profes-
sionals were interviewed in two groups. See Supplemental
Material Table 1 for demographics, time of completion
and opinions on the IPOS from all respondents.
Main changes to finalise the Portuguese IPOS were: (i)
to remove numerals indicative of the scores in the differ-
ent items in each response square; (ii) to alter the ques-
tionnaire instructions of the healthcare professional to
clarify that the last response option should be used for
“not applicable” as well as “unknown”; (iii) to alter the
instructions in the patient questionnaire to avoid repeti-
tion of requesting the respondent to choose the best an-
swer and mark it with an “x” in the corresponding
square; (iv) to add space between the groups of items in
page 2 as well as add the time period to which the items
pertain to, namely, “During the last week”.
Data collection
Data were missing at random (Little’s MCAR test
showed Chi-Square = 2452.9; p = 0.213). Missing data
varied between 1 and 5%, as expected in palliative popula-
tions, most questionnaire items presented a non-parametric
distribution, so the imputation of the median was used to
handle missing data.
Demographic and clinical data
1703 individuals were screened in nine centres of main-
land Portugal between July 1st 2015 and 20th February
2016. Among them, 1410 (82.8%) were immediately
considered non eligible, mainly because they were not
enrolled in palliative care, were less than 18 years of age,
or could not read, write or understand Portuguese. We
excluded 140 (8.2%) more individuals mainly because
they were excessively suffering, or they were cognitively
deteriorated. There were 18 (1.1%) eligible patients who
declined participation.
A total of 135 (7.9%) patients were included and filled
the questionnaires without help, most (98; 72.6%) were
approached to participate in the study whilst in out-
patient consultations. Table 1 presents demographic and
clinical information for respondent patients.
Most patients were older male with low literacy,
mainly diagnosed with cancer, receiving specialized
palliative care, and in a stable phase of their illness.
However, their mean quality of life index was low, they
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Table 1 Demographic and clinical information of participating patients
Patients
Variable Value N %
Gender Male 77 57.0
Female 58 43.0
Age (years) < 65 57 42.2
65+ 78 57.8
Min – Max 29–94
Mean ± standard deviation 66.8 ± 12.7
Education Reads and writes 5 3.7
4 years 81 60.0
6 years 20 14.8
9 years 10 7.4
10 years to college 19 14.0
Geographical Region North 74 54.8
Centre 25 18.5
South 36 26.7
Area Urban 94 69.6
Peri-urban 31 23.0
Rural 10 7.4
Place of care Primary care 28 20.7
Hospital 25 18.5
Palliative care 82 60.7
Cancer diagnosis Yes 109 80.7
No 26 19.3
Life expectancy Less than 6months 48 35.6
Between 6months and 1 year 47 34.8
More than 1 year 40 29.6
Phase of illness Stable 64 47.4
Unstable 28 20.7
Deteriorating 43 31.9
Quality of Life Mean Index 31.4
Mean VAS 53.7
Anxiety (HADS) Normal (0–7) 11 8.1
Mild (8–10) 16 11.9
Moderate (11–14) 66 48.9
Severe (15–21) 42 31.1
Mean ± standard deviation 12.7 ± 3.1
Depression (HADS) Normal (0–7) 17 12.6
Mild (8–10) 63 46.7
Moderate (11–14) 48 35.6
Severe (15–21) 7 5.2
Mean ± standard deviation 10.1 ± 2.6
EORTC Quality of Life 49.7 ± 20.6
EORTC Functional scales Physical functioning 48.4 ± 28.7
Role functioning 51.5 ± 34.7
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showed high scores of anxiety and low physical and
emotional functioning scores. Their main reported
symptoms were fatigue and pain.
In Table 2 we present the mean scores for each IPOS
item when filled by patients and assigned by healthcare
professionals. By comparing, for each patient, his/her
score and the one provided by the healthcare professional,
we also present the results from the paired samples t-test.
Emotional symptoms are more prevalent, especially
those measuring family and patient anxiety, and depres-
sion. Regarding physical symptoms, the presence of
weakness or lack of energy, pain, and poor mobility were
the most prevalent. Vomiting, nausea and shortness of
breath are the symptoms less present in these patients.
Comparing patients and professionals scores, we note
lower scores among professionals regarding physical
Table 1 Demographic and clinical information of participating patients (Continued)
Patients
Variable Value N %
Emotional functioning 62.5 ± 24.2
Cognitive functioning 75.4 ± 23.2
Social functioning 66.9 ± 30.9
EORTC Symptom scales Fatigue 49.0 ± 25.4
Nausea and vomiting 8.1 ± 16.5
Pain 35.1 ± 29.1
Dyspnoea 14.1 ± 26.5
Insomnia 32.6 ± 34.4
Appetite loss 30.9 ± 36.6
Constipation 24.9 ± 31.7
Diarrhoea 9.1 ± 20.9
Financial impact 32.6 ± 35.8
Table 2 Descriptive statistics of IPOS items (%) - n = 134
Patients Staff |t| (Sig.)
Physical symptoms Pain 42.0 35.9 1.914 (p = 0.058)
Shortness of breath 15.0 14.8 0.118 (p = 0.906)
Lack of energy 42.1 45.6 1.598 (p = 0.112)
Nausea 12.6 11.3 0.733 (p = 0.465)
Feeling sick 8.7 6.4 1.801 (p = 0.074)
Poor appetite 34.5 30.4 1.374 (p = 0.172)
Constipated 28.2 19.0 3.923 (p < 0.001)
Wounds in mouth or mouth dry 31.4 10.6 7.450 (p < 0.001)
Sleepiness 33.1 14.7 7.493 (p > 0.001)
Lack of mobility 39.2 41.4 1.029 (p = 0.305)
Total subscale score 28.7 23.3 5.233 (p < 0.001)
Emotional symptoms Anxiety 56.9 54.5 0.921 (p = 0.359)
Family/friends worry 70.3 62.4 2.693 (p = 0.008)
Depression 47.3 42.0 2.103 (p = 0.037)
Feeling at peace 35.8 45.0 3.151 (p = 0.002)
Total subscale score 52.7 50.7 1.206 (p = 0.230)
Communications/
practical issues
Sharing feelings 62.9 48.6 4.285 (p < 0.001)
Info needs 83.6 80.9 0.939 (p = 0.349)
Practical problems 76.5 68.8 2.487 (p = 0.015)
Total subscale score 73.9 65.4 4.217 (p < 0.001)
P values below 0.05, considered statistically significant, are in bold letters
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symptoms as constipation, wounds in mouth or mouth
dry, and trouble in sleep, as well as the emotional symp-
toms, being worried about family and friends, depressed, or
feeling at peace. How patients’ practical problems have
been solved is also scored lower by healthcare
professionals.
The input from the open question about the main con-
cerns patients reported and those observed and reported
by professionals are presented in Supplemental Material
Table 2. Completion rates of all 3 items was higher in pro-
fessionals than in patients. Regarding rate of completeness
for each of the items, 1a had the highest (71% for patients
and 92% for professionals), item 1b followed (36% for pa-
tients and 64% for professionals) and finally, item 1c was
the least responded to with 17% of patients completing it
and 30% of professionals completing it. From the patient
perspective, patients are more concerned with the disease
itself and with their health status. Pain also occupies a
relevant position, as does the concern about the impact of
their health status in their family members. The concerns
about their actual dependence, about their future and
about death are also relevant for patients. Regarding the
perspective of healthcare professionals, they much more
recognise patients’ concerns about the future, as well as
about their disease and health status, and about treat-
ments they will be submitted to.
Reliability
Table 3 shows the test-retest reliability scores for both
patient and professionals’ versions, as well as the internal
consistency of the three main dimensions and the global
score of IPOS.
IPOS items showed good test-retest reliability (H1),
with ICC from 0.794 (feeling sick) to 0.950 (poor appe-
tite) for patients, and from 0.456 (family/friends worry)
to 0.925 (shortness of breath) for professionals.
The Cronbach’s α measuring the internal consistency
is, in general, moderate to high (H2) with scores of 0.657
for patients and 0.705 for healthcare professionals. All
dimensions had also acceptable internal consistency, ex-
cept for the dimension ‘communication/practical issues’
for patients that showed a very weak score.
Validity
Having the content validity assured by the interviews
with experts (patients and professionals) during the cul-
tural adaptation of both versions, we started by testing
construct validity. We used some sociodemographic and
clinical variables and studied the behaviour of the
Table 3 IPOS reliability for patients and professionals
Patients Staff
ICC Alpha ICC Alpha
Physical symptoms 0.725 0.660
Pain 0.884 0.862
Shortness of breath 0.810 0.925
Lack of energy 0.851 0.713
Nausea 0.812 0.759
Feeling sick 0.794 0.644
Poor appetite 0.950 0.821
Constipated 0.938 0.706
Wounds in mouth or mouth dry 0.895 0.696
Sleepiness 0.882 0.632
Lack of mobility 0.887 0.852
Emotional symptoms 0.615 0.658
Anxiety 0.909 0.525
Family/friends worry 0.871 0.456
Depression 0.899 0.625




Sharing feelings 0.810 0.514
Info needs 0.860 0.720
Practical problems 0.938 0.598
All dimensions All items 0.657 0.705
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different IPOS dimensions for different levels of those
variables, regarding the patient version, for which the
mean scores are presented in Table 4.
Of the three sociodemographic variables studied,
IPOS could only discriminate emotional symptoms
based on gender (H3). Females showed more physical
symptoms than male patients did. Regarding clinical
variables, communication and practical issues have dif-
ferent significant scores regarding the various places of
care(H6), meaning that higher scores correspond to in-
patients and lower scores to primary care. IPOS could
discriminate practical issues, based on cancer diagnos-
is(H7), physical and emotional symptoms based on life
expectancy(H8) both for patient and professional di-
mensions. IPOS could discriminate physical and emo-
tional symptoms based on phase of illness(H9), for
professional dimensions, and physical symptoms from
patients’ viewpoint. In summary, cancer patients
showed more easiness in solving practical issues, pa-
tients with less than 6 months of life expectancy re-
ported higher physical and emotional symptoms and
were equally perceived as such by staff, and these were
able to better recognise physical and emotional symp-
toms among those patients who were in a more deteri-
orating phase of their illness.
Regarding criterion validity, Table 5 shows there
were good correlations between EQ-5D-3L index and
IPOS physical and emotional symptoms and a good
correlation between EQ-VAS and all IPOS dimen-
sions. This measure correlates poorly with practical
issues (H10).
In relation to the EORTC (H11) the functional index
showed significant correlations with both IPOS physical
and emotional symptoms, the symptoms scale correlated
stronger with physical and emotional symptoms and
moderately with practical issues, and the quality of life
measure correlated significantly with physical symptoms
and with emotional symptoms.
Finally, the HADS (H12) correlated poorly with phys-
ical symptoms and significantly with emotional symp-
toms. The anxiety indicator also correlated significantly
with IPOS practical issues.
Discussion
The Portuguese IPOS is a reliable and valid measure, ap-
propriate to use with patients with advanced, incurable
illnesses. Regarding the translation process and cultural
adaptation there were, as expected, adjustments made to
the direct translation of some concepts and in the over-
all appearance of the measure. These changes are well
aligned with the literature, mainly with the French [18]
and Swedish [19] translations and cultural adaptions of
this measure. Regarding the open question items 1a, 1b
and 1c, these gave insights to some of the issues worry-
ing patients, which was important and informative for
healthcare professionals to act upon in real time. This
item could also provide a good starter for the clinical
appointment.
Regarding psychometric properties, there was good
agreement between patient and professional ratings, es-
pecially in most physical symptoms. It is expected that
some proxy ratings are lower for professionals and
higher when done by proxy family ratings and indeed,
there were lower proxy ratings for some items. This
measure also discriminates well between life expectancy
(surprise question) and phase of illness. IPOS is compar-
able with other measures in the field, as it showed
moderate correlations with the EORTC-QLQ-C30, the
HADS and the EQ-5D-3L.
These results show commonalities with validity of the
original English and German IPOS versions [1] and the
Japanese version [20]. Indeed, the original measures
showed similar results for most psychometric properties
and it is noted that the moderate correlations are
expected given that IPOS measures how a person is
affected by their symptoms rather than the severity of
symptoms.
Strengths and limitations
This was a multicentre study in different regions of the
country and in different settings within all three sectors
of the Portuguese healthcare system, thus securing good
heterogeneity of our sample. As expected, in the specia-
lised palliative care services, we observed a higher num-
ber of patients with a life expectancy under 6 months, 42
Table 5 Criterion validity (Correlations)
Measure Indicator Physical
symptoms
Emotional symptoms Practical Issues
EQ-5D-3L Index −0.529 (p < 0.001) −0.395 (p < 0.001) 0.028 (p = 0.748)
EQ-VAS −0.309 (p < 0.001) −0.356 (p < 0.001) 0.221 (p = 0.010)
EORTC Functional index −0.532 (p < 0.001) − 0.500 (p < 0.001) 0.156 (p = 0.071)
Symptoms scale 0.659 (p < 0.001) 0.371 (p < 0.001) −0.220 (p = 0.010)
Quality of Life −0.399 (p < 0.001) − 0.358 (p < 0.001) 0.020 (p = 0.822)
HADS Anxiety −0.155 (p = 0.072) − 0.443 (p < 0.001) 0.243 (p = 0.005)
Depression 0.226 (p = 0.008) 0.308 (p < 0.001) −0.088 (p = 0.312)
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(52.5%), and in the health primary care services most
patients were expected to live over one year, 20 (80%).
This shows that patients with palliative needs are
present in all settings in all sectors of the healthcare sys-
tem and that the IPOS is good to identify those needs in
patients with advanced disease. However, there are limi-
tations, namely, most participants were outpatients, so
there is less representation of more ill patients; also, it
would have been interesting to capture functional status
and non-cancer diagnoses, to better understand our
sample.
Conclusions
The Portuguese IPOS is a reliable and valid measure
which can be used to identify palliative needs in people
with advanced diseases, whether used by the patient or
by a healthcare professional (proxy). Given the potential
uses of patient centred outcome measures in clinical
settings and healthcare system levels (micro, meso and
macro), the Portuguese IPOS is an invaluable tool to be
used in clinical practice and in research.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s12904-020-00685-z.
Additional file 1: Table 1. Demographics, time of completion and
main opinions about IPOS by patients and healthcare professionals.
Table 2. Open question 1a, 1b, 1c: “What have been the main concerns
in the past week?”
Abbreviations
IPOS: Integrated Palliative care Outcome Scale; COSMIN: COnsensus-based
Standards for the selection of health Measurement INstruments; EQ-5D-
3L: Portuguese EuroQol questionnaire; EQ-VAS: numeric analogue visual
scale; EORTC QLQ-C30: European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire Core; HADS: Hospital Anxiety and
Depression Scale; ICC: intraclass correlation coefficient
Acknowledgements
To all patients who contributed for data collection our most profound
appreciation. Without them this work would not have been possible. Thank
you to all healthcare professionals and care teams who performed data
collection: Palliative care service of S. João de Deus de Montemor-o-Novo
Hospital; Oncology service of CHVNG/E Hospital, Moreira Pinto, Enrique Dias,
Ana Joaquim, Teresa Sarmento, Sandra Custódio; Palliative care teal (EIHSCP)
of CHVNGaia/Espinho, EPE hospital; home palliative care team od IPOLFG
hospital and palliative care team of IPOLFG, EPE hospital; palliative care ser-
vice of São João, E.P.E. hospital, Cátia Coelho; palliative care team of Unidade
Local de Saúde do Nordeste, Duarte Soares, Sara Fernandes, Silvia Asseiro;
healthcare centre São Julião - Figueira da Foz, Sara Marques Baptista, Sandra
Amaral, Pedro Figueiredo, Ana Castro; healthcare centre AlphaMouro and
palliaitive care unit of Lisboa Norte, EPE hospital.
Authors’ contributions
BA performed study procedures and collection of data, BA and PLF
performed analysis of data and were responsible for drafting and editing of
the manuscript. Both authors approved the final manuscript.
Funding
This study was funded by Calouste Gulbenkian Foundation – Programa
Gulbenkian Inovar em Saúde. Bárbara Antunes was funded by Foundation
for Science and Technology (FCT) - Grant number PD/BD/113664/2015,
Faculty of Medicine, University of Porto. The Doctoral Program Clinical and
Health Services Research was funded by FCT - Grant number PD/0003/2013.
Currently Bárbara Antunes is funded by the National Institute for Health
Research (NIHR) Applied Research Collaboration East of England (ARC EoE)
programme. The views expressed are those of the author(s) and not
necessarily those of the NHS, the NIHR or the Department of Health and
Social Care. The funding organizations had no role in the design of the
study, collection, analysis, interpretation of the data, or writing of the
manuscript.
Availability of data and materials
The datasets generated and/or analysed during the current study are
available from the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethical approval was granted from all Research Ethics Committees’ included
centres and was in accordance with the 1964 Helsinki declaration and its
later amendments or comparable ethical Standard: Comissão de Ética para a
Saúde do Centro Hospitalar de S. João – Entidade Pública Empresarial (no
reference number); Comissão de Ética para a Saúde Administração Regional
de Saúde Centro - 77/2015; Comissão de Ética para a Saúde de Lisboa e Vale
do Tejo – 6801/CES/2015; Comissão de Ética do Centro Hospitalar de Vila
Nova de Gaia/Espinho – 275/2015; Conselho de Investigação e da Comissão
de Ética do Instituto Português de Oncologia de Lisboa Francisco Gentil,
Entidade Pública Empresarial – UIC/967 n° 89/2015; Comissão de Ética
Instituto S. João de Deus – CEISJD03_15; Comissão de Ética do Centro
Académico de Medicina de Lisboa – 51/15; Comissão de Ética da Unidade
Local de Saúde do Nordeste Entidade Pública Empresarial – p°, CE.
Informed written (signed) consent was obtained from all participants




The authors declare that they have no competing interests.
Author details
1Primary Care Unit, Department of Public Health and Primary Care, University
of Cambridge, Cambridge, UK. 2Centre for Health Studies and Research,
University of Coimbra, Coimbra, Portugal. 3Faculty of Economics, University of
Coimbra, Coimbra, Portugal.
Received: 26 June 2020 Accepted: 15 November 2020
References
1. Murtagh FE, Ramsenthaler C, Firth A, Groeneveld EI, Lovell N, Simon ST,
et al. A brief, patient- and proxy-reported outcome measure in advanced
illness: Validity, reliability and responsiveness of the Integrated Palliative care
Outcome Scale (IPOS). Palliat Med. 2019;33(8):1045–57.
2. Hearn J, Higginson IJ. Development and validation of a core outcome scale
measure for palliative care: the palliative care. Qual Health Care. 1999;8:
219e227.
3. Mokkink LB, Terwee CB, Patrick DL, Alonson J, Stratford PW, Knol DL, et al.
The COSMIN checklist for assessing the methodological quality of studies
on measurement properties of health status measurement instruments: an
international Delphi study. Qual Life Res. 2010;19:539–49. https://doi.org/10.
1007/s11136-010-9606-8.
4. Acquadro C, Conway K, Hareendran A, Aaronson N, European Regulatory
Issues and Quality of Life Assessment (ERIQA) Group. Literature review of
methods to translate health-related quality of life questionnaires for use in
multinational clinical trials. Value Health. 2008;11(3):509–21.
5. POS Development Team. Manual for validation and cross-cultural
adaptation of the Palliative Care Outcome Scale. A resource for palliative
care. Available at: pos-pal.org. Accessed June 10, 2019.
6. Acuñna E, Rodriguez C. The treatment of missing values and its effect on
classifier accuracy. In: Banks D, House L, FR MM, Arabie P, Gaul W, editors.
Classification, Clustering and Data Mining Applications. Berlin: Springer;
2004. p. 639e648.
Antunes and Ferreira BMC Palliative Care          (2020) 19:178 Page 10 of 11
7. Ferreira LN, Ferreira PL, Pereira LN, Oppe M. The valuation of the EQ-5D in
Portugal. Qual Life Res. 2014;23(2):413–23.
8. Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population
norms. Qual Life Res. 2014;23(2):425–30.
9. Ferreira PL. The Portuguese version of the EORTC QLQ-C30. Eur J Gynaecol
Oncol. 1997;18(4):324.
10. Pais-Ribeiro J, Pinto C, Santos C. Validation study of the portuguese version
of the QLC-C30-V.3. Psic. Saúde Doenças. 2008;9(1):89–102.
11. Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M. Validation
study of a Portuguese version of the hospital anxiety and depression scale.
Psychol Health Med. 2006;12:2,225–37. https://doi.org/10.1080/
13548500500524088.
12. Eagar K, Watters P, Currow DC, et al. The Australian palliative care outcomes
collaboration (PCOC) measuring the quality and outcomes of palliative care
on a routine basis. Aust Health Rev. 2010;34:186–92.
13. Masso M, Allingham SF, Banfield M, et al. Palliative care phase: inter-rater
reliability and acceptability in a national study. Palliat Med. 2015;29:22–30.
14. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation
coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.
15. Terwee CB, Bot SD, de Boer MR, van der Windt DAWM, Knol DL, Dekker LM,
et al. Quality criteria were proposed for measurement properties of health
status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
16. de Vet HC, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine.
Cambridge: Cambridge University Press; 2011.
17. Cohen J. Statistical power analysis for the behavioural sciences. New York:
Lawrence Erlbaum Associates; 1988.
18. Sterie A, Bernard M. Challenges in a six-phase process of questionnaire
adaptation: findings from the French translation of the Integrated Palliative
care Outcome Scale. BMC Palliat Care. 2019;18:38. https://doi.org/10.1186/
s12904-019-0422-9.
19. Beck I, Möller UO, Malmström M, Klarare A, Samuelsson H, Hagelin CL, et al.
Translation and cultural adaptation of the Integrated Palliative care
Outcome Scale including cognitive interviewing with patients and staff.
Palliative Care. 2017;16:49.
20. Sakurai H, Miyashita M, Imai K, Miyamoto S, Otani H, Oishi A, et al. Validation
of the Integrated Palliative care Outcome Scale (IPOS) – Japanese version.
Jpn J Clin Oncol. 2019:1–6. https://doi.org/10.1093/jjco/hyy203.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Antunes and Ferreira BMC Palliative Care          (2020) 19:178 Page 11 of 11
